Drug Shortage Report for JAMP-MOXIFLOXACIN

Last updated on 2025-01-23 History
Report ID 207295
Drug Identification Number 02472120
Brand name JAMP-MOXIFLOXACIN
Common or Proper name Moxifloxacin Ophthalmic Solution USP
Company Name JAMP PHARMA CORPORATION
Market Status MARKETED
Active Ingredient(s) MOXIFLOXACIN
Strength(s) 0.5%
Dosage form(s) SOLUTION
Route of administration OPHTHALMIC OPHTHALMIC
Packaging sizes (GTIN)

Click here to see a list of all reports for this drug.

(See additional packaging sizes)
Additional packaging sizes 3 mL
ATC code S01AE
ATC description ANTIINFECTIVES
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2023-10-16
Estimated end date 2025-12-31
Actual end date
Shortage status Actual shortage
Updated date 2025-01-23
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 1310 RUE NOBEL
BOUCHERVILLE, QUEBEC
CANADA J4B 5H3
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v12 2025-01-23 French Compare
v11 2025-01-23 English Compare
v10 2024-12-03 French Compare
v9 2024-12-03 English Compare
v8 2024-07-29 French Compare
v7 2024-07-29 English Compare
v6 2024-03-19 French Compare
v5 2024-03-19 English Compare
v4 2023-11-29 French Compare
v3 2023-11-29 English Compare
v2 2023-10-18 French Compare
v1 2023-10-18 English Compare

Showing 1 to 12 of 12